Literature DB >> 26654182

Treatment of ruptured complex and large/giant ruptured cerebral aneurysms by acute coiling followed by staged flow diversion.

Waleed Brinjikji1, Mariangela Piano2, Shanna Fang3, Guglielmo Pero2, David F Kallmes1,4, Luca Quilici2, Luca Valvassori2, Emilio Lozupone5, Harry J Cloft1,4, Edoardo Boccardi2, Giuseppe Lanzino1,4.   

Abstract

OBJECT Flow-diversion treatment has been shown to be associated with high rates of angiographic obliteration; however, the treatment is relatively contraindicated in the acute phase following subarachnoid hemorrhage (SAH) as these patients require periprocedural dual antiplatelet therapy. Acute coiling followed by flow diversion has emerged as an intriguing and feasible treatment option for ruptured complex and giant aneurysms. In this study the authors report outcomes and complications of patients with ruptured aneurysms undergoing coiling in the acute phase followed by planned delayed flow diversion. METHODS This case series includes patients from 2 institutions. All patients underwent standard endovascular coiling in the acute phase after SAH with the intention and plan to proceed with flow diversion at a later date. Outcomes studied included angiographic occlusion, procedure-related complications, and long-term clinical outcome as measured using the modified Rankin Scale. RESULTS A total of 31 patients underwent coiling in the acute phase with the intention to undergo flow diversion at a later date. The mean aneurysm size was 15.8 ± 7.9 mm. Of the 31 patients undergoing coiling, 4 patients could not undergo further flow-diverter therapy: 3 patients (9.7%) died of complications of subarachnoid hemorrhage and 1 patient had permanent morbidity as a result of perioperative ischemic stroke (3.1%). Twenty-seven patients underwent staged placement of flow diverters after adequate recovery. The median time to treatment was 16 weeks. There was one case of aneurysm rebleeding following coil treatment. There were no cases of permanent morbidity or mortality resulting from flow-diverter treatment. Twenty-four patients underwent imaging follow-up; 18 of these patients had aneurysms that were completely or nearly completely occluded (58.1% on an intent-to-treat basis). At last follow-up (mean 18.3 months), 25 patients had mRS scores ≤ 2 (80.6% on an intent-to-treat basis). CONCLUSIONS Staged treatment of ruptured complex and giant intracranial aneurysms with coiling in the acute phase and flow-diverter treatment following recovery from SAH is both safe and effective. In this series, no cases of rebleeding occurred during the interval between coiling and flow diversion. This strategy should be considered as a valid option in patients presenting with these challenging ruptured aneurysms.

Entities:  

Keywords:  ICA = internal carotid artery; PED = Pipeline Embolization Device; SAH = subarachnoid hemorrhage; WFNS = World Federation of Neurosurgical Societies; aneurysm; coil; flow diverter; mRS = modified Rankin Scale; vascular disorders

Mesh:

Year:  2015        PMID: 26654182     DOI: 10.3171/2015.6.JNS151038

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  Current Strategies in the Treatment of Intracranial Large and Giant Aneurysms.

Authors:  Matthias Gmeiner; Andreas Gruber
Journal:  Acta Neurochir Suppl       Date:  2021

2.  Treatment of Intracranial Aneurysms With Pipeline Embolization Device: Newer Applications and Technical Advances.

Authors:  Santosh B Murthy; Jharna Shah; Halinder S Mangat; Philip Stieg
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

Review 3.  Flow Diversion in Ruptured Intracranial Aneurysms: A Meta-Analysis.

Authors:  T P Madaelil; C J Moran; D T Cross; A P Kansagra
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-22       Impact factor: 3.825

Review 4.  Blood Flow Diversion as a Primary Treatment Method for Ruptured Brain Aneurysms-Concerns, Controversy, and Future Directions.

Authors:  Brian P Walcott; Matthew J Koch; Christopher J Stapleton; Aman B Patel
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

5.  Treatment of giant intracranial aneurysms: long-term outcomes in surgical versus endovascular management.

Authors:  Antonio Santoro; Daniele Armocida; Francesco Paglia; Marta Iacobucci; Luigi Valentino Berra; Luca D'Angelo; Carlo Cirelli; Giulio Guidetti; Francesco Biraschi; Giampaolo Cantore
Journal:  Neurosurg Rev       Date:  2022-10-21       Impact factor: 2.800

6.  A novel treatment of a patient with a giant ruptured middle cerebral artery aneurysm by acute coiling followed by scheduled Pipeline flex placement.

Authors:  Shikai Liang; Ren Yuan; Xianli Lv
Journal:  Neuroradiol J       Date:  2020-07-16

7.  Coil Now, Pipe Later: Two-stage Treatment for Acute Intracranial Aneurysm Rupture.

Authors:  Ali S Haider; Tijani Osumah; Hawk Cambron; Suraj Sulhan; Fariha Murshid; Steven Vayalumkal; Richa Thakur; Umair Khan; Kennith F Layton
Journal:  Cureus       Date:  2017-11-25

8.  Evaluation of clinical and anatomical outcome of staged stenting after acute coiling of ruptured intracranial aneurysms.

Authors:  Benjamin Mine; Thomas Bonnet; Juan Carlos Vazquez-Suarez; Noémie Ligot; Boris Lubicz
Journal:  Interv Neuroradiol       Date:  2019-12-10       Impact factor: 1.610

9.  A Single Center Experience with Coil Embolization for Cerebral Aneurysms Greater than 10 mm in the Internal Carotid Artery.

Authors:  Kensuke Suzuki; Ryotaro Suzuki; Tomoji Takigawa; Nobuyuki Shimizu; Yoshiyuki Matsumoto; Yoshiko Fujii; Yuki Inoue; Yoshiki Sugiura; Koji Hirata; Kyoji Tsuda; Yosuke Kawamura; Issei Takano; Ryuta Nakae; Masaya Nagaishi; Yoshihiro Tanaka; Akio Hyodo
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-03-02       Impact factor: 1.742

10.  Treatment of Intracranial Aneurysms with the Pipeline Embolization Device Only: a Single Center Experience.

Authors:  Maus Volker; Mpotsaris Anastasios; Borggrefe Jan; Abdullayev Nuran; Liebig Thomas; Dorn Franziska; Stavrinou Pantelis; Chang De-Hua; Kabbasch Christoph
Journal:  Neurointervention       Date:  2018-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.